Obesity and epithelial ovarian cancer survival: a systematic review and meta-analysis.

Abstract:

BACKGROUND:Studies on the association between obesity and ovarian cancer survival have had conflicting results. We reviewed and quantitatively summarized the existing evidence, exploring potentially important sources of variability, such as the timing of body mass index (BMI) assessment, BMI cut points, references used in multivariate analysis, and ovarian cancer stage. METHODS:Eligible studies were searched using MEDLINE (PubMed), EMBASE, and Cochrane Central Register of Controlled Trials, relevant bibliographies were manually reviewed for additional studies. Adjusted hazard ratios (HRs) from individual studies were pooled using a random effects model. RESULTS:17 cohort studies of 929 screened articles were included in the final analysis. Obesity in early adulthood and obesity 5 years before ovarian cancer diagnosis were associated with poor patient survival (early adulthood: pooled HR 1.67; 95% CI 1.29-2.16; 5 years prediagnosis: pooled HR 1.35; 95% CI 1.03-1.76). However, the results for obesity at diagnosis depended on whether BMI was analyzed as a categorical or continuous variable. Analysis of obesity with BMI as a categorical variable did not affect ovarian cancer prognosis (pooled HR 1.07; 95% CI 0.95-1.21); obesity with BMI as a continuous variable showed slightly poorer survival with each incremental increase in BMI (pooled HR 1.02; 95% CI 1.01-1.04). CONCLUSIONS:Obesity 5 years before ovarian cancer diagnosis and obesity at a young age were associated with poor prognosis. The association between obesity at diagnosis and survival of ovarian cancer patients still remains equivocal. BMI at diagnosis cannot be a prognostic factor for the survival of ovarian cancer patients. Further well-designed studies are needed to elucidate the variety effect of obesity on the survival of ovarian cancer patients.

journal_name

J Ovarian Res

authors

Bae HS,Kim HJ,Hong JH,Lee JK,Lee NW,Song JY

doi

10.1186/1757-2215-7-41

subject

Has Abstract

pub_date

2014-04-22 00:00:00

pages

41

issn

1757-2215

pii

1757-2215-7-41

journal_volume

7

pub_type

杂志文章,meta分析,评审
  • Establishment and characterization of a cell line (HCH-1) originating from a human clear cell carcinoma of the ovary.

    abstract:BACKGROUND:Cell lines are very useful for both clinical and basic research. The establishment of ovarian, malignant tumor cell lines with aggressive histology is especially important. We describe the establishment and characterization of a new human clear cell carcinoma cell line of the ovary. RESULTS:The cell line HC...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-016-0242-y

    authors: Yamada T,Hattori K,Satomi H,Okazaki T,Mori H,Hirose Y

    更新日期:2016-06-04 00:00:00

  • Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis.

    abstract:BACKGROUND:Resistance to apoptosis is a major problem in ovarian cancer (OC) and correlates with poor prognosis. Osteoprotegerin (OPG) is a soluble secreted factor that acts as a decoy receptor for receptor activator of NF-κB ligand (RANKL) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). OPG has be...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/1757-2215-6-82

    authors: Lane D,Matte I,Laplante C,Garde-Granger P,Rancourt C,Piché A

    更新日期:2013-11-23 00:00:00

  • The clinicopathological significance of miR-1307 in chemotherapy resistant epithelial ovarian cancer.

    abstract:BACKGROUND:We aimed to examine the expression of miR-1307 in chemosensitive and chemoresistant epithelial ovarian cancer tissues and cell lines and to analyze the clinicopathological significance of miR-1307 in ovarian cancer. METHODS:MicroRNA microarray was used to screen differentially expressed microRNAs between th...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-015-0143-5

    authors: Zhou Y,Wang M,Wu J,Jie Z,Chang S,Shuang T

    更新日期:2015-04-09 00:00:00

  • Use of aromatase inhibitors in practice of gynecology.

    abstract:PURPOSE:The conversion of androgens into estrogens by aromatase is called aromatization and is inhibited by aromatase inhibitors (AIs). The aim of this article is to evaluate the use of aromatase inhibitors in gynecological diseases such as endometriosis, leiomyoma, estrogen- dependent gynecologic neoplasia and inferti...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章,评审

    doi:10.1186/s13048-015-0131-9

    authors: Usluogullari B,Duvan C,Usluogullari C

    更新日期:2015-02-25 00:00:00

  • Comparison of quartz vials with polypropylene vials for rapid cryopreservation of human ovarian tissue.

    abstract:BACKGROUND:Because higher survival of follicles during the freezing/thawing procedure improves the quality of cryopreserved tissue reimplanted after oncological therapies, defining an optimal method for human ovarian tissue cryopreservation remains a major issue in this field. One option to improve the cryopreservation...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-016-0268-1

    authors: Scheiner D,Bracone G,Imesch P,Fink D,Hehl J,Imthurn B

    更新日期:2016-09-26 00:00:00

  • Increased expression of the leptin receptor in human ovaries affected by endometrioma and detection of high levels of leptin in the ovarian endometriomal fluid.

    abstract:BACKGROUND:This study was designed to investigate leptin levels in the fluid in ovarian endometriomas (OEs) and to compare the expression of leptin and its receptors (OBR) in ovarian tissue affected by endometrioma in infertile women to its expression in the normal ovarian tissue of fertile controls without endometrios...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/1757-2215-7-2

    authors: Zendron C,Gonçalves HF,Cavalcante FS,Pereira TR,Evangelista A,Ramos CF,Oliveira MA

    更新日期:2014-01-08 00:00:00

  • IL-12 Expressing oncolytic herpes simplex virus promotes anti-tumor activity and immunologic control of metastatic ovarian cancer in mice.

    abstract:BACKGROUND:Despite advances in surgical aggressiveness and conventional chemotherapy, ovarian cancer remains the most lethal cause of gynecologic cancer mortality; consequently there is a need for new therapeutic agents and innovative treatment paradigms for the treatment of ovarian cancer. Several studies have demonst...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-016-0282-3

    authors: Thomas ED,Meza-Perez S,Bevis KS,Randall TD,Gillespie GY,Langford C,Alvarez RD

    更新日期:2016-10-27 00:00:00

  • Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients.

    abstract::High-Grade Serous Ovarian Carcinoma (HGSOC) is the predominant histotype of epithelial ovarian cancer (EOC), characterized by advanced stage at diagnosis, frequent TP53 mutation, rapid progression, and high responsiveness to platinum-based-chemotherapy. To date, standard first-line-chemotherapy in advanced EOC include...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-016-0238-7

    authors: Mignogna C,Staropoli N,Botta C,De Marco C,Rizzuto A,Morelli M,Di Cello A,Franco R,Camastra C,Presta I,Malara N,Salvino A,Tassone P,Tagliaferri P,Barni T,Donato G,Di Vito A

    更新日期:2016-05-21 00:00:00

  • Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome.

    abstract:BACKGROUND:Polycystic Ovary Syndrome (PCOS) is a widespread reproductive disorder characterized by a disruption of follicular growth and anovulatory infertility. In women with PCOS, follicular growth and ovulation can be induced by subcutaneous injections of low doses of follicle stimulating hormone (FSH). The aim of t...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-015-0192-9

    authors: Tessaro I,Modina SC,Franciosi F,Sivelli G,Terzaghi L,Lodde V,Luciano AM

    更新日期:2015-10-06 00:00:00

  • Clinical implication of the serum galectin-1 expression in epithelial ovarian cancer patients.

    abstract:BACKGROUND:galectin-1 has been implicated in tumor invasion and metastasis and is frequently over-expressed in epithelial ovarian cancer (EOC), but its potential as a biomarker remains unclear. In this novel study, we have explored the possible use of galectin-1 as a biomarker for EOC. METHODS:galectin-1 in sera was e...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-015-0206-7

    authors: Chen L,Yao Y,Sun L,Zhou J,Liu J,Wang J,Li J,Tang J

    更新日期:2015-11-21 00:00:00

  • Correction to: PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma.

    abstract::Following publication of the original article [1], the authors opted to correct the incorrect e-mail address of the corresponding author from 82-55-360-1850chungsu1982@gmail.com to chungsu1982@gmail.com , grant in the Acknowledgements section and Author details. Below are the updated version of the Acknowledgements an...

    journal_title:Journal of ovarian research

    pub_type: 已发布勘误

    doi:10.1186/s13048-019-0540-2

    authors: Kim KH,Choi KU,Kim A,Lee SJ,Lee JH,Suh DS,Kwon BS,Hwang C

    更新日期:2019-07-23 00:00:00

  • Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin, bevacizumab, docetaxel, and cyclophosphamide (GFIP/BDC) for heavily pretreated relapsed epithelial ovarian, fallopian tube and primary peritoneal cancer.

    abstract:BACKGROUND:Epithelial ovarian cancer has the highest fatality rate of all gynecologic malignancies. Although the majority of patients achieve complete clinical response after initial cytoreductive surgery and platinum-based chemotherapy, most recur and almost all will eventually acquire platinum-resistance for which tr...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-019-0506-4

    authors: Cohen S,Schwartz M,Dottino P,Beddoe AM

    更新日期:2019-04-25 00:00:00

  • SIRT1 activator (SRT1720) improves the follicle reserve and prolongs the ovarian lifespan of diet-induced obesity in female mice via activating SIRT1 and suppressing mTOR signaling.

    abstract:BACKGROUND:The prevalence of obesity is increasing worldwide and significantly affects fertility and reproduction in both men and women. Our recent study has shown that excess body fat accelerates ovarian follicle development and follicle loss in rats. The aim of the present study is to explore the effect of SIRT1 acti...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-014-0097-z

    authors: Zhou XL,Xu JJ,Ni YH,Chen XC,Zhang HX,Zhang XM,Liu WJ,Luo LL,Fu YC

    更新日期:2014-10-21 00:00:00

  • Evidence of metachronous development of ovarian teratomas: a case report of bilateral mature cystic teratomas of the ovaries and systematic literature review.

    abstract:BACKGROUND:Mature cystic teratomas are usually found in the ovaries. They are bilateral in 10 to 15% of cases and multiple cystic teratomas may be present in one ovary. The aim of this study is to clarify if development of mature cystic teratomas of the ovaries in a single host is metachronous or due to autoimplant or ...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章,评审

    doi:10.1186/s13048-017-0313-8

    authors: Wang WC,Lai YC

    更新日期:2017-03-14 00:00:00

  • Ovarian hyperstimulation syndrome and prophylactic human embryo cryopreservation: analysis of reproductive outcome following thawed embryo transfer.

    abstract:OBJECTIVE:To review utilisation of elective embryo cryopreservation in the expectant management of patients at risk for developing ovarian hyperstimulation syndrome (OHSS), and report on reproductive outcome following transfer of thawed embryos. MATERIALS AND METHODS:Medical records were reviewed for patients undergoi...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/1757-2215-1-7

    authors: Sills ES,McLoughlin LJ,Genton MG,Walsh DJ,Coull GD,Walsh AP

    更新日期:2008-11-06 00:00:00

  • Locally existing endothelial cells and pericytes in ovarian stroma, but not bone marrow-derived vascular progenitor cells, play a central role in neovascularization during follicular development in mice.

    abstract:BACKGROUND:Neovascularization is necessary for follicular growth. Vascularization is first observed in preantral follicles, and thereafter the vasculature markedly increases in follicles undergoing development. Neovascularization includes angiogenesis and vasculogenesis. Vasculogenesis is the formation of new blood ves...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/1757-2215-7-10

    authors: Kizuka-Shibuya F,Tokuda N,Takagi K,Adachi Y,Lee L,Tamura I,Maekawa R,Tamura H,Suzuki T,Owada Y,Sugino N

    更新日期:2014-01-21 00:00:00

  • Rate of rebound in follicle growth after cessation of ovarian stimulation in initial non-responders: a prospective cohort study.

    abstract::Previously anecdotally observed rebounds in follicle growth after interruption of exogenous gonadotropins in absolute non-responders were the impetus for here reported study. In a prospective cohort study, we investigated 49 consecutive patients, absolutely unresponsive to maximal exogenous gonadotropin stimulation, f...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-021-00765-5

    authors: Gleicher N,Weghofer A,Darmon SK,Barad DH

    更新日期:2021-01-09 00:00:00

  • BRIP1, RAD51C, and RAD51D mutations are associated with high susceptibility to ovarian cancer: mutation prevalence and precise risk estimates based on a pooled analysis of ~30,000 cases.

    abstract:BACKGROUND:It is estimated that more than 20% of ovarian cancer cases are associated with a genetic predisposition that is only partially explained by germline mutations in the BRCA1 and BRCA2 genes. Recently, several pieces of evidence showed that mutations in three genes involved in the homologous recombination DNA r...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章,meta分析

    doi:10.1186/s13048-020-00654-3

    authors: Suszynska M,Ratajska M,Kozlowski P

    更新日期:2020-05-02 00:00:00

  • MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1.

    abstract:BACKGROUND:Epithelial ovarian cancer (EOC) is still a major gynecologic problem with poor 5 year survival rate due to distance metastases, despite routine surgery and chemotherapy. The precise underlying molecular mechanisms that trigger EOC migration and invasion are unclear. Recent studies suggest that the expression...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/1757-2215-6-84

    authors: Zhang H,Wang Q,Zhao Q,Di W

    更新日期:2013-11-26 00:00:00

  • Lnc-GULP1-2:1 affects granulosa cell proliferation by regulating COL3A1 expression and localization.

    abstract:BACKGROUNDS:Long non-coding RNA is a novel group of non-protein coding transcripts over 200 nt in length. Recent studies have found that they are widely involved in many pathological and physiological processes. In our previous study, we found that lnc-GULP1-2:1 was significantly down-regulated in the ovarian cortical ...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-021-00769-1

    authors: Yao G,Kong Y,Yang G,Kong D,Xu Y,He J,Xu Z,Bai Y,Fan H,He Q,Sun Y

    更新日期:2021-01-20 00:00:00

  • Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer.

    abstract::The original article [1] contains errors in Fig. 3C, Results and Discussion. ...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章,已发布勘误

    doi:10.1186/s13048-020-00628-5

    authors: Wu H,Li R,Zhang Z,Jiang H,Ma H,Yuan C,Sun C,Li Y,Kong B

    更新日期:2020-03-13 00:00:00

  • Metabolic active peritoneal sites affect tumor debulking in ovarian and peritoneal cancers.

    abstract:RATIONALE AND OBJECTIVES:To evaluate the impact of metabolic parameters in the peritoneal cavity on the likelihood of achieving complete tumor debulking in patients with ovarian and peritoneal cancers. MATERIALS AND METHODS:Forty-nine patients with ovarian and peritoneal cancers were included, who underwent pre-operat...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-020-00662-3

    authors: Tsoi TT,Chiu KWH,Chu MY,Ngan HYS,Lee EYP

    更新日期:2020-05-20 00:00:00

  • A comprehensive review of the impact of COVID-19 on human reproductive biology, assisted reproduction care and pregnancy: a Canadian perspective.

    abstract::Currently, the world is in the seventh month of the COVID-19 pandemic. Globally, infections with novel SARS-CoV-2 virus are continuously rising with mounting numbers of deaths. International and local public health responses, almost in synchrony, imposed restrictions to minimize spread of the virus, overload of health...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章,评审

    doi:10.1186/s13048-020-00737-1

    authors: Madjunkov M,Dviri M,Librach C

    更新日期:2020-11-27 00:00:00

  • Development of a multi-gene-based immune prognostic signature in ovarian Cancer.

    abstract:BACKGROUND:Various components of the immune system play a critical role in the prognosis and treatment response in ovarian cancer (OC). Immunotherapy has been recognized as a hallmark of cancer but the effect is contradictional. Reliable immune gene-based prognostic biomarkers or regulatory factors are necessary to be ...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-021-00766-4

    authors: Cao T,Shen H

    更新日期:2021-01-28 00:00:00

  • Increased androgen receptor expression in serous carcinoma of the ovary is associated with an improved survival.

    abstract:BACKGROUND:Altered androgen hormone homeostasis and androgen receptor (AR) activity have been implicated in ovarian carcinogenesis but the relationship between AR expression in ovarian cancer and clinical outcome remains unclear. METHODS:In this study, the prognostic impact of AR expression was investigated using immu...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/1757-2215-3-14

    authors: Nodin B,Zendehrokh N,Brändstedt J,Nilsson E,Manjer J,Brennan DJ,Jirström K

    更新日期:2010-06-17 00:00:00

  • The value of DCE-MRI in assessing histopathological and molecular biological features in induced rat epithelial ovarian carcinomas.

    abstract:BACKGROUND:To investigate dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) for assessing histopathological and molecular biological features in induced rat epithelial ovarian carcinomas (EOCs). METHODS:7,12-dimethylbenz[A]anthracene (DMBA) was applied to induce EOCs in situ in 46 SD rats. Conventional MR...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-017-0362-z

    authors: Yuan SJ,Qiao TK,Qiang JW,Cai SQ,Li RK

    更新日期:2017-09-26 00:00:00

  • Histological analysis of arteriovenous anastomosis-like vessels established in the corpus luteum of cows during luteolysis.

    abstract:BACKGROUND:The mechanisms regulating the function and regression of the corpus luteum (CL) have not yet been elucidated in detail. The regressed CL of cows was previously reported to be filled with unusual vessels like arteriovenous anastomosis (AVA); however how these vessels are being established during luteolysis re...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-016-0277-0

    authors: Nio-Kobayashi J,Miyazaki K,Hashiba K,Okuda K,Iwanaga T

    更新日期:2016-10-19 00:00:00

  • YTHDF2, a protein repressed by miR-145, regulates proliferation, apoptosis, and migration in ovarian cancer cells.

    abstract::RNA methylation can reverse the methylation modification at the RNA level, which is an extremely important epigenetic modification. The function and mechanism of YTHDF2, as a reader of m6A modification, in epithelial ovarian cancer (EOC) have not been elucidated so far. This study aimed to investigate how YTHDF2 and m...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-020-00717-5

    authors: Li J,Wu L,Pei M,Zhang Y

    更新日期:2020-09-18 00:00:00

  • Primary ovarian angiosarcoma: a rare and recognizable ovarian tumor.

    abstract::The diagnosis of primary angiosarcoma of ovary is still a challenge as it has no specific clinical symptoms and is easily confused with other malignant neoplasms in morphology. Here, we described a case of primary ovarian angiosarcoma and reviewed the literature. A 47-year-old female showed a left ovary mass. Grossly,...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-021-00771-7

    authors: Ye H,Lin M,Li R,Qin S,Hou G,Chen H,Li X

    更新日期:2021-01-28 00:00:00

  • Does metformin improve in vitro maturation and ultrastructure of oocytes retrieved from estradiol valerate polycystic ovary syndrome-induced rats.

    abstract:BACKGROUND:Metformin decreases polycystic ovary syndrome (PCOS) symptoms, induces ovulation, and may improve developmental competence of in vitro oocyte maturation. This study was designed to define the effects of metformin on the characteristics of in vitro oocyte maturation in estradiol valerate (EV) PCOS-induced rat...

    journal_title:Journal of ovarian research

    pub_type: 杂志文章

    doi:10.1186/s13048-015-0203-x

    authors: Mesbah F,Moslem M,Vojdani Z,Mirkhani H

    更新日期:2015-11-14 00:00:00